Megadose of Hydroxocobalamin for the Treatment of Pernicious Anemia

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 27, 2017

Primary Completion Date

December 1, 2018

Study Completion Date

December 1, 2019

Conditions

Megaloblastic Anemia NosPernicious Anemia

Interventions

DRUG

Hydroxocobalamin 10,000mcg, Thiamin 100mg, Pyridoxine 50mg

Single intramuscular dose of hydroxocobalamin 10,000mcg, Thiamin 100mg, Pyridoxine 50mg.

Trial Locations (1)

Hospital Universitario Dr. Jose E Gonzalez UANL, Monterrey

All Listed Sponsors

lead

Hospital Universitario Dr. Jose E. Gonzalez

OTHER

NCT03372447 - Megadose of Hydroxocobalamin for the Treatment of Pernicious Anemia | Biotech Hunter | Biotech Hunter